NDC 71610-698 – Terazosin Hydrochloride

Terazosin Hydrochloride 2 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71610-698

Product details

Brand name
Terazosin Hydrochloride
Generic name
Terazosin Hydrochloride
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA074823
Marketed since
June 30, 2020
Listing expires
December 31, 2026
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin Hydrochloride →

Package NDC codes (7)

Package NDCDescriptionSince
71610-698-3030 CAPSULE in 1 BOTTLE (71610-698-30)Apr 4, 2023
71610-698-5360 CAPSULE in 1 BOTTLE (71610-698-53)Apr 4, 2023
71610-698-6090 CAPSULE in 1 BOTTLE (71610-698-60)Apr 4, 2023
71610-698-70120 CAPSULE in 1 BOTTLE (71610-698-70)Apr 4, 2023
71610-698-80180 CAPSULE in 1 BOTTLE (71610-698-80)Apr 4, 2023
71610-698-92270 CAPSULE in 1 BOTTLE (71610-698-92)Apr 4, 2023
71610-698-94360 CAPSULE in 1 BOTTLE (71610-698-94)Apr 4, 2023

Other Terazosin Hydrochloride products